ISSN 1308-7649 | E-ISSN 2148-3817
RELATED ARTICLES
Case Report
Congenital Intratympanic Cholesteatoma in an Adult Patient: A Case Report and Review of the Literature
(J Int Adv Otol 2016; 12: 119-124)
DOI: 10.5152/iao.2016.1807
Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment
(J Int Adv Otol 2017; 13: 285-288)
DOI: 10.5152/iao.2017.2772
Review
European Position Statement on Diagnosis, and Treatment of Meniere’s Disease*
(J Int Adv Otol 2018; 14: 317-321)
DOI: 10.5152/iao.2018.140818
Original Article
Protective Effect of Ginkgo Biloba Extract on Gentamicin-Induced Structural Changes of Calcite-Gelatin Composite
(J Int Adv Otol 2015; 11: 179-182)
DOI: 10.5152/iao.2015.1605
N-acetylcysteine Prevents Gentamicin Ototoxicity in a Rat Model
(J Int Adv Otol 2015; 11: 12-18)
DOI: 10.5152/iao.2015.650
The Protective Effect of Intratympanic Alpha Lipoic Acid on Cisplatin-Induced Ototoxicity on Rats
(J Int Adv Otol 2014; 10: 217-221)
DOI: 10.5152/iao.2014.369
The Role of High Dose Intratympanic Dexamethasone as Salvage Therapy for Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol 2017; 13: 318-321)
DOI: 10.5152/iao.2017.3896
Intratympanic Steroid Treatment of Bell’s Palsy in Patients with Comorbid Disease: A Preliminary Report
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2019.5415
Cochlear and Vestibular Effects of Combined Intratympanic Gentamicin and Dexamethasone
(J Int Adv Otol 2017; 13: 47-52)
DOI: 10.5152/iao.2016.2181
Comparison of Long-Term Outcome of Intratympanic Dexamethasone Therapy between Acute Noise-Induced Tinnitus and Acute Idiopathic Tinnitus
(J Int Adv Otol 2017; 13: 53-60)
DOI: 10.5152/iao.2016.2632
Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere’s Disease Patients
(J Int Adv Otol 2016; 12: 92-97)
DOI: 10.5152/iao.2016.2177
Selective Window Application of Gentamicin+ Dexamethasone in Meniere's Disease
(J Int Adv Otol 2017; 13: 243-246)
DOI: 10.5152/iao.2017.3483
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol 2018; 14: 451-455)
DOI: 10.5152/iao.2018.4871
A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2016; 12: 321-325)
DOI: 10.5152/iao.2016.3014
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2018.4871
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2018.4871
Key Words
Authors
All
Author's Corner
Reviewer's Corner
Survey
AVES | Copyright © 2019 The European Academy of Otology and Neurotology | Latest Update: 15.08.2019